Functional imaging of mood and anxiety disorders

Journal of Neuroimaging

Volumn 16, Issue 1, 2006, Pages 1-10

  Deckersbach, Thilo ^a   Dougherty, Darin D ^a   Rauch, Scott L ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Affective neuroscience; Anxiety disorders; Cognitive neuroscience; Functional magnetic resonance imaging; Mood disorders; Neuroimaging; Position emission tomography

Indexed keywords

AFFECT; AMYGDALOID NUCLEUS; ANXIETY DISORDER; BIPOLAR DISORDER; COGNITION; CORPUS STRIATUM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOMANIA; LIMBIC CORTEX; MAJOR DEPRESSION; MANIA; MOOD DISORDER; NEUROIMAGING; NEUROSCIENCE; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; POSTTRAUMATIC STRESS DISORDER; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANXIETY DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MOOD DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 32544456907     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1177/1051228405001474     Document Type: Review

References (130)

1. Rauch SL. Neuroimaging and the neurobiology of anxiety disorders. In: Davidson RJ, Scherer K, Goldsmith HH, eds. Handbook of Affective Sciences. New York: Oxford University Press, 2003:963-975.
2. Rauch SL, Baxter LR. Neuroimaging of OCD and related disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Theory and Management. Boston: Mosby, 1998:289-317.
3. Rauch SL, Shin LM, Whalen PJ, Pitman RK. Neuroimaging and the neuroanatomy of PTSD. CNS Spectrum 1998a;3(suppl 2):3041.
4. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiat 2000;48:813-829.
5. Mayberg HS. Limbic-cortical dysregulation: A proposed model of depression. J Neuropsych Clin N 1997;9:471-481.
6. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiat 1999;156:675-682.
7. Aggleton JP (ed.). The Amygdala: Neurobiological Aspects of Emotion, Memory and Mental Dysfunction. New York: Wiley-Liss, 1992.
8. LeDoux JE. The Emotional Brain. New York: Simon and Schuster, 1996.
9. Whalen PJ, Rauch SL, Etcoff NL, McInerney S, Lee MB, Jenike MA. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neuroscience 1998;18:411-418.
10. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;152:973-981.
11. Rauch SL, Whalen PJ, Dougherty DD, Jenike MA. Neurobiological models of obsessive compulsive disorders. In: Jenike MA, Baer L, Minichiello WE, eds. Obsessive-Compulsive Disorders: Practical Management. Boston: Mosby. 1998b:222-253.
12. Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 1992;22(3):607-615.
13. Baxter LR, Schwartz JM, Phelps ME, et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiat 1989;46:243-250.
14. George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression 1994;2:59-72.
15. Mayberg HS, Lewis PJ, Regenold W, et al. Paralimbic hypoperfusion in unipolar depression. J Nucl Med 1994;35:929-934.
16. Drevets WC, Videen TO, Price JL, et al. A functional anatomical study of unipolar depression. J Neurosci 1992;12:3628-3641.
17. Drevets WC, Price JL, Simpson JR Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827.
18. Liotti M, Mayberg HS, Brannan SK, McGinnis S, Jerabek P, Fox PT. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: implications for affective disorders. Biol Psychiat 2000;48(1):30-42.
19. Damasio AR, Grabowski TJ, Bechara A, Damasio H, Ponto LL, Parvizi J, Hichwa RD. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci 2000;3(10):1049-1056.
20. Brevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 2001;11(2):240-249.
21. Bench CJ, Frackowiak RS, Dolan RJ. Changes in regional cerebral blood flow on recovery from depression. Psychol Med 1995;25(2):247-261.
22. Goodwin GM, Austin MP, Dougall N, et al. State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment. J Affect Disorders 1993;29(4):243-253.
23. Buchsbaum MS, Wu J, DeLisi LE, et al. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J Affect Disorders 1986;10:137-152.
24. Brody AL, Saxena S, Silverman DH, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiat Res 1999;91(3):127-139.
25. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiat 2001;50(3):159-170.
26. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiat 2000;48(8):830-843.
27. Kennedy SH, Evans KR, Kruger S, et al. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiat 2001;158(6):899-905.
28. Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharm 2002;12(6):527-544.
29. Smith GS, Reynolds CF 3rd, Pollock B, et al. Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. Am J Psychiat 1999;156(5):683-689.
30. Teneback CC, Nahas Z, Speer AM, Molloy M, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsych Clin N 1999;11(4):426-435.
31. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ECT. Am J Psychiat 2001;158(2):305-308.
32. Malizia AL. The frontal lobes and neurosurgery for psychiatric disorders. J Psychopharmacol 1997;11(2):179-187.
33. Martin SD, Martin E, Rai SS, Richardson MA, Royall R. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydro chloride: Preliminary findings. Arch Gen Psychiat 2001;58(7):641-648.
34. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: An fMRI study. Biol Psychiatry 2001;50(9):651-658.
35. Davidson RJ, Irwin W, Anderle MJ, Kalin NH. The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003;160:64-75.
36. Rubin E, Sackheim HA, Prohovnik I, et al. Regional cerebral blood flow in mood disorder: IV. Comparison of mania and depression. Psychiat Res-Neuroim 1995;61:1-10.
37. Blumberg HP, Stern E, Ricketts S, et al. Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiat 1999;156:1986-1988.
38. Blumberg HP, Stern E, Martinez D, et al. Increased anterior cingulate and caudate activity in bipolar mania. Biol Psychiat 2000;48:1045-1052.
39. Blumberg HP, Leung HC, Skudlarski P, et al. A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiat 2003;60(6):601-609.
40. Goodwin GM, Cavanagh JTO, Glabus MF, et al. Uptake of 99mTc-exametazime shown by single photon emission computed tomography before and after lithium withdrawal in bipolar patients: associations with mania. Br J Psychiat 1997;170:426-430.
41. Rubinsztein JS, Fletcher PC, Rogers RD, et al. Decision-making in mania: a PET study. Brain 2001;124:2550-2563.
42. Migliorelli R, Starkstein SE, Teson A, de Quiros G, Vazquez S, Leiguarda R, Robinson RG. SPECT findings in patients with primary mania. J Neuropsych Clin N 1993;5(4):379-383.
43. Al-Mousawi AH, Evans N, Ebmeier KP, et al. Limbic dysfunction in schizophrenia and mania: A study using sup 18 F-labelled Fluorodeoxyglucose and positron emission tomography. Br J Psychiat 1996;169:509-516.
44. Gyulai L, Alavi A, Broich K, et al. I-123 Iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: a clinical Study. Biol Psychiat 1997;41:152-161.
45. O'Connell RA, van Heertum RL, Luck D, et al. Single-photon emission computed tomography of the brain in acute mania and schizophrenia. J Neuroimaging 1995;5:101-104.
46. Elliott R, Ogilvie A, Rubinsztein JS, Calderon G, Dolan RJ, Sahakian BJ. Abnormal ventral frontal response during performance of an affective go/no go task in patients with mania. Biol Psychiat 2004;55(12):1163-1170.
47. Drevets WC, Price JL, Videen TO, et al. Metabolic abnormalities in the subgenual prefrontal cortex and ventral striatum in mood disorder. Neurosci Abstr 1995;21:260.
48. Elliott R, Baker SC, Rogers RD, O'Leary DA, et al. Pre-frontal dysfunction in depressed patients performing a complex planning task: a study using positron emission tomography. Psychol Med 1997;27:931-942.
49. Deckersbach T, Dougherty DD, Savage CR, Sachs G, Rauch S. Impaired recruitment of prefrontal cortex and hippocampus during episodic memory encoding in euthymic bipolar disorder. Poster presented at the Annual Meeting of the Society of Biological Psychiatry, New York. 2004.
50. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiat 2002;180:313-319.
51. Cavanagh JT, Van Beck M, Muir W, Blackwood DH. Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 2002;180:320-326.
52. Deckersbach T, Savage CR, Reilly-Harrington N, Clark L, Sachs G, Rauch SL. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies. Bipolar Disord 2004;6:233-244.
53. Mesulam M-M. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Ann Neurol 1990;28:597-613.
54. Posner MI, Petersen SE, Fox PT, et al. Localization of cognitive operations in the human brain. Science 1988;240:1627-1631.
55. Frith CD, Friston KJ, Liddle PF, et al. Willed action and the prefrontal cortex in man: a study with PET. P Roy Soc Lond B Biol 1991;244:241-246.
56. Paus T, Petrides M, Evans AC, et al. Role of the human anterior cingulate cortex in the control of oculomotor, manual, and speech responses: a positron emission tomography study. J Neurophysiol 1993;70:453-469.
57. Badgaiyan RD, Posner MI. Mapping the cingulate cortex in response selection and monitoring. Neuroimage 1998;7:255-260.
58. Turken AU, Swick D. Response selection in the human anterior cingulate cortex. Nat Neurosci 1999;2:920-924.
59. Gehring WJ, Knight RT. Prefrontal-cingulate interactions in action monitoring. Nat Neurosci 2000;3:516-520.
60. Luu P, Flaisch T, Tucker DM. Medial frontal cortex in action monitoring. J Neurosci 2000;20:464-469.
61. Clark VP, Fannon S, Lai S, et al. Responses to rare visual target and distractor stimuli using event-related fMRI. J Neurophysiol 2000;83:3133-3139.
62. Carter CS, Braver TS, Barch DM, et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998;280:747-749.
63. Botvinic M, Nystrom LE, Fissell K, et al. Conflict monitoring versus selection- for-action in anterior cingulate cortex. Nature 1999;402:179-181.
64. Carter CS, Macdonald AM, Botvinick M, et al. Parsing executive processes: strategic vs. evaluative functions of the anterior cingulate cortex. Proc Natl Acad Sci USA 2000;97:1944-1948.
65. Bush G, Vogt BA, Holmes J, et al. Dorsal anterior cingulate cortex: a role in reward-based decision making. Proc Natl Acad Sci USA 2002;1:523-528.
66. Lemelin S, Baruch P, Vincent A, et al. Distractibility and processing resource deficit in major depression. Evidence for two attentional processing models. J Nerv Ment Dis 1997;185:542-548.
67. Lemelin S, Baruch P. Clinical psychomotor retardation and attention in depression. J Psychiat Res 1998;32:81-88.
68. Degl'Innocenti A, Backman AH. Executive deficits in major depression. Acta Psychiat Scand 1998;97:182-188.
69. Lemelin S, Baruch P, Vincent A, et al. Attention disturbances in clinical depression. J Nerv Ment Dis 1996;184:114-121.
70. Trichard C, Martinot JL, Alagille M, et al. Time course of prefrontal lobe dysfunction in severely depressed inpatients: a longitudinal neuropsychological study. Psychol Med 1995;25:79-85.
71. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiat 2001;158:1605-1611.
72. Kerr N, Phillips ML. Cognitive processing biases and shifts in emotive tone: the stroop task and emotionally selective information processing in bipolar affective disorder. Poster presented at the Annual Meeting of the Society for Biological Psychiatry, Philadelphia. 2002.
73. Cohen R, Lohr I, Paul R, et al. Impairments in attention and effort among patients with major affective disorders. JNeuropsych Cli N 2001;13:385-395.
74. George MS, Ketter TA, Parekh PI, et al. Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry 1997;9:55-63.
75. Amaral DG, Price JL, Pitkanen A, et al. Anatomical organization of the primate amygdaloid complex. In: Aggleton JP, ed. The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. New York: Wiley-Liss. 1992:1-66.
76. Pandya DN, Van Hoeseon GW, Mesulam M-M. Efferent connections of the cingulate gyrus in the rhesus monkey. Exp Brain Res 1981;42:319-330.
77. Vogt BA, Nimchinsky EA, Vogt LJ, et al. Human cingulate cortex: surface features, flat maps, and cytoarchi-tecture. J Comp Neurol 1995;359:490-506.
78. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001;158(3):405-411.
79. Mayberg HM, Liotti M, Brannan SK, et al. Disease and state-specific effect of mood challenge on rCBF. Neuroimage 1998;7:S901.
80. Moriarty J. Neural organization of aggression and dyscontrol. In: Timble MR, Cummings JL, eds. Contemporary Behavioral Neurology. Boston: Butterworth-Heinemann, 1997.
81. Scarpa A, Raine A. Violence associated with anger and impulsivity. In: Borod JC, edr. The Neuropsychology of Emotion. Oxford: Oxford University Press, 2000:320-339.
82. Kent JM, Sullivan GM, Rauch SL. The Neurobiology of fear: relevance to panic disorder and posttraumatic stress disorder. Psychiatric Ann 2000;30:733-742.
83. Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS. Can't shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002;51(9):693-707.
84. Semple WE, Goyer P, McCormick R, et al. Preliminary report: brain blood flow using PET in patients with posttraumatic stress disorder and substance-abuse histories. Biol Psychiatry 1993;34:115-118.
85. Rauch SL, van der Kolk BA, Fisler RE, et al. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 1996;53:380-387.
86. Shin LM, McNally RJ, Kosslyn SM, et al. Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related posttraumatic stress disorder: a PET investigation. Am J Psychiatry 1999;156:575-584.
87. Bremner JD, Narayan M, Staib LH, Southwick SM, McGlashum T, Charney DS. Neural correlates of memories of childhood sexual abuse in women with and without posttraumatic stress disorder. Am J Psychiatry 1999a;156:1787-1795.
88. Bremner JD, Staib LH, Kaloupek D, et al. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry 1999b;45:806-816.
89. Bremner JD, Innis RB, Ng CK, et al: Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1997a;54:246-254.
90. Liberzon I, Taylor SF, Amdur R, et al. Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 1999;45:817-826.
91. Shin LM, Kosslyn SM, McNally RJ, et al. Visual imagery and perception in posttraumatic stress disorder: a positron emission tomographic investigation. Arch Gen Psychiatry 1997;54:233-241.
92. Rauch SL, Whalen PJ, Shin LM, et al. Exaggerated amygdala response to masked fearful vs. happy facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 2000;47:769-776.
93. Baxter LR, Phelps ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211-218.
94. Baxter L, Schwartz J, Mazziotta J, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988;145:1560-1563.
95. Machlin SR, Harris GJ, Pearlson GD, et al. Elevated medial-frontal cerebral blood flow in obsessive-compulsive patients: A SPECT study. Am J Psychiatry 1991;148:1240-1242.
96. Nordahl TE, Benkelfat C, Semple W, et al. Cerebral glucose metabolic rates in obsessive-compulsive disorder. Neuropsychopharmacology 1989;2:23-28.
97. Rubin RT, Villaneuva-Myer J, Ananth J, et al. Regional xenon-133 cerebral blood flow and cerebral Technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Arch Gen Psychiatry 1992;49:695-702.
98. Swedo SE, Shapiro MB, Grady CL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:518-523.
99. Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681-689.
100. Benkelfat C, Nordahl TE, Semple WE, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine. Arch Gen Psychiatry 1990;47:840-848.
101. Hoehn-Saric R, Pearlson GD, Harris GJ, et al. Effects of fluoxetine on regional cerebral blood flow in obsessive-compulsive patients. Am J Psychiatry 1991;148:1243-1245.
102. Perani D, Colombo C, Bressi S, et al. FDG PET study in obsessive-compulsive disorder: a clinical metabolic correlation study after treatment. Br J Psychiatry 1995;166:244-250.
103. Schwartz JM, Stoessel PW, Baxter LR, et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification. Arch Gen Psychiatry 1996;53:109-113.
104. Swedo SE, Pietrini P, Leonard HL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder: revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690-694.
105. Brody AL, Saxena S, Schwartz JM, et al. FDG-PET predictors of response to behavioral therapy versus pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res: Neuroimaging 1998;84:1-6.
106. Saxena S, Brody AL, Maidment KM, et al. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 1999;21:683-693.
107. McGuire PK, Bench CJ, Frith CD, et al. Functional anatomy of obsessive-compulsive phenomena. Br J Psychiatry 1994;164:459-468.
108. Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 15O-labeled CO2 and positron emission tomography. Arch Gen Psychiatry 1994;51:62-70.
109. Breiter HC, Rauch SL, Kwong KK, et al. Functional magnetic resonance imaging of symptom provocation in obsessive compulsive disorder. Arch Gen Psychiatry 1996b;53:595-606.
110. Rauch SL, Savage CR, Alpert NM, et al. Probing striatal function in obsessive compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry 1997a;9:568-573.
111. Rauch SL, Whalen PJ, Curran T, et al. Probing striatothalamic function in OCD and TS using neuroimaging methods. In: Cohen DJ, Goetz C, Jankovic J, eds. Tourette Syndrome and Associated Disorders. Philadelphia: Lippincott, Williams & Wilkins. (in press-a).
112. Rauch SL, Savage CR, Brown HD, et al. A PET investigation of implicit and explicit sequence learning. Hum Brain Mapping 1995b;3:271-286.
113. Rauch SL, Whalen PJ, Savage CR, et al. Striatal recruitment during an implicit sequence learning task as measured by functional magnetic resonance imaging. Hum Brain Mapping 1997b;5:124-132.
114. Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology 2002;27(5):782-791.
115. Rauch SL, Dougherty DD, Cosgrove GR, et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001;50(9):659-667.
116. Deckersbach T, Savage CR, Curran T, et al. A study of parallel implicit and explicit information processing in patients with obsessive-compulsive disorder. Am J Psychiatry 2002:1780-1782.
117. Pissiota A, Frans O, Fernandez M, von Knorring L, Fischer H, Fredrikson M. Neurofunctional correlates of posttraumatic stress disorder: a PET symptom provocation study. Eur Arch Psychiatry Clin Neurosci 2002;252:68-75.
118. Lanius RA, Williamson PC, Densmore M, et al. Neural correlates of traumatic memories in posttraumatic stress disorder: a functional MRI investigation. Am J Psychiatry 2001;158:1920-1922.
119. Dale AM, Liu AK, Fischl BR, et al. Dynamic statistical parametric mapping: combining fMRI and MEG for high-resolution imaging of cortical activity. Neuron 2000;26:55-67.
120. Cannistraro PA, Rauch SL. Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 2003;37:8-25.
121. Lanius RA, Williamson PC, Densmore M, Boksman K, Neufeld RW, Gati JS, Menon RS. The nature of traumatic memories: a 4-T FMRI functional connectivity analysis. Am J Psychiatry 2004;161:36-44.
122. Sapolsky RM, Krey LC, McEwen BS. Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J Neurosci 1985;5:1222-1227.
123. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neuroscience 1990;10:2897-2902.
124. Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry 1992;32:756-765.
125. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301.
126. Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharm 1999;21:474-484.
127. Feldman S, Conforti N. Participation of the dorsal hippocampus in the glucocorticoid feedback effect on adrenocortical activity. Neuroendocrinol 1980;30:52-55.
128. Herman J, Schafer M, Young E, et al. Evidence for hippocampal regulation of neuroendocrine neurons of hypothalamo-pituitary-adrenocortical axis. J Neurosci 1989;9:3072-3082.
129. Raichle ME. BOLD insights. Nature 2001;412:127-129.
130. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology 1989;39:349-354.